Development Agreements in the Biotechnology Industry

607 Contracts & Agreements

Browse by Company

ACADIA PHARMACEUTICALS INC (5 contracts)
Achaogen, Inc. (4)
Acorda Therapeutics (2)
Adaptimmune Therapeutics PLC (3)
ADURO BIOTECH, INC. (1)
Aeglea BioTherapeutics, Inc. (1)
AGENUS INC (3)
ALBIREO PHARMA, INC. (1)
Alkermes plc. (1)
Allakos Inc. (1)
Alliqua BioMedical, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (1)
Altimmune, Inc. (5)
ALX ONCOLOGY HOLDINGS INC (2)
AMARILLO BIOSCIENCES INC (4)
AMARIN CORP PLC (2)
AmpliPhi Biosciences Corp (1)
Anixa Biosciences Inc (2)
Apellis Pharmaceuticals, Inc. (2)
Arbutus Biopharma Corp (1)
ARCA biopharma, Inc. (4)
Arcturus Therapeutics Holdings Inc. (4)
Atara Biotherapeutics, Inc. (5)
Athenex, Inc. (5)
ATHERSYS, INC (47)
Avita Therapeutics, Inc. (2)
BIO-PATH HOLDINGS INC (1)
bioAffinity Technologies, Inc. (1)
BIOCRYST PHARMACEUTICALS INC (17)
BIOMARIN PHARMACEUTICAL INC (1)
BioNexus Gene Lab Coporation (2)
BioRestorative Therapies, Inc. (1)
BIOTIME INC (4)
bluebird bio, Inc. (1)
Bone Biologics Corp (1)
BullFrog AI Holdings, Inc. (1)
CALADRIUS BIOSCIENCES, INC. (1)
CANCER GENETICS, INC (1)
Capstone Therapeutics Corp. (6)
CASI Pharmaceuticals, Inc. (4)
CATALYST BIOSCIENCES, INC. (6)
Cell Source, Inc. (4)
Celldex Therapeutics, Inc. (1)
Celsion CORP (4)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (9)
CHIMERIX INC (28)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (1)
CONSTELLATION PHARMACEUTICALS INC (1)
CONTRAFECT Corp (2)
Corvus Pharmaceuticals, Inc. (1)
CRISPR Therapeutics AG (2)
Curative Biotechnology Inc (3)
Cyclerion Therapeutics, Inc. (1)
CytoDyn Inc. (1)
Cytokinetics, Incorporated (13)
CYTORI THERAPEUTICS, INC. (1)
DiaMedica Therapeutics Inc. (3)
Dicerna Pharmaceuticals Inc (1)
Digital Development Partners, Inc. (4)
DYADIC INTERNATIONAL INC (1)
Dynamics Special Purpose Corp. (1)
Eagle Pharmaceuticals, Inc. (3)
Edge Therapeutics, Inc. (2)
Eiger BioPharmaceuticals, Inc. (3)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (22)
Entasis Therapeutics Holdings Inc. (1)
Evelo Biosciences, Inc. (1)
EVOLUTIONARY GENOMICS, INC. (1)
Exelixis (9)
FIBROGEN INC (17)
FS Development Corp. (5)
FS Development Corp. II (5)
Fusion Pharmaceuticals Inc. (2)
Gritstone Oncology, Inc. (2)
GTX INC (27)
Harpoon Therapeutics, Inc. (4)
HISTOGENICS CORP (2)
HUMANIGEN, INC (1)
iBio, Inc. (2)
IDERA PHARMACEUTICALS, INC. (1)
Immune Therapeutics, Inc. (1)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (1)
Inhibikase Therapeutics, Inc. (2)
Inmune Bio, Inc. (1)
Intec Pharma Ltd. (1)
INTERCEPT PHARMACEUTICALS, INC. (4)
IONIS PHARMACEUTICALS INC (2)
IOVANCE BIOTHERAPEUTICS, INC. (3)
Isoray, Inc. (2)
Kindred Biosciences, Inc. (2)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (3)
Ligand Pharmaceuticals Incorporated (4)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
LONGEVERON LLC (2)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (2)
MATEON THERAPEUTICS INC (2)
Matinas BioPharma Holdings, Inc. (1)
MEDICINOVA INC (1)
MiMedx Group, Inc. (1)
Moderna, Inc. (6)
Moleculin Biotech, Inc. (4)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
NEUROCRINE BIOSCIENCES INC (1)
NEWLINK GENETICS CORP (27)
NORTHWEST BIOTHERAPEUTICS INC (1)
NOVAVAX INC (3)
Omega Therapeutics, Inc. (2)
ONCOSEC MEDICAL Inc (7)
Orchard Therapeutics plc (1)
Orgenesis Inc. (1)
Passage BIO, Inc. (2)
PIERIS PHARMACEUTICALS, INC. (3)
PLURISTEM THERAPEUTICS INC (16)
PORTOLA PHARMACEUTICALS INC (1)
PROTEON THERAPEUTICS INC (1)
PROTEOSTASIS THERAPEUTICS, INC. (1)
Prothena Corp plc (1)
Radius Health, Inc. (5)
Regeneron Pharmaceuticals (4)
REGENXBIO Inc. (2)
Regulus Therapeutics Inc. (1)
Revolution Medicines, Inc. (1)
RHYTHM PHARMACEUTICALS, INC. (4)
RITTER PHARMACEUTICALS INC (1)
Sana Biotechnology, Inc. (1)
SANGAMO THERAPEUTICS, INC (2)
Sarepta Therapeutics, Inc. (1)
Savara Inc (5)
SEATTLE GENETICS INC (17)
SELLAS Life Sciences Group, Inc. (2)
Social Capital Suvretta Holdings Corp. III (1)
SOPHIRIS BIO INC. (3)
Spectrum Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (10)
TENAX THERAPEUTICS, INC. (1)
Tocagen Inc (1)
Tonix Pharmaceuticals Holding Corp. (1)
Tracon Pharmaceuticals, Inc. (7)
TREVENA INC (2)
Trovagene, Inc. (2)
U.S. Stem Cell, Inc. (1)
Ultragenyx Pharmaceutical Inc. (2)
Unicycive Therapeutics, Inc. (1)
VACCINEX, INC. (1)
Vaxcyte, Inc. (8)
VERACYTE, INC. (1)
Vertex Pharmaceuticals Inc (10)
Verve Therapeutics, Inc. (1)
VICAL INC (1)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (5)
VistaGen Therapeutics, Inc. (1)
VITRO DIAGNOSTICS INC (3)
WINDTREE THERAPEUTICS INC (3)
Xencor Inc (3)
Xenetic Biosciences, Inc. (1)
XOMA Corp (3)
ZIOPHARM ONCOLOGY INC (12)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

RESEARCH AND DEVELOPMENT AGREEMENT

Development Agreements

Trovagene, Inc.

Biotechnology

2013

Amendment No.3 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...

Development Agreements

Vir Biotechnology, Inc.

2024

Amendment No. 2 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...

Development Agreements

Vir Biotechnology, Inc.

2024

English Translation of Third Addendum to Product Development Agreement, dated October 16, 2024

Development Agreements

AMARILLO BIOSCIENCES INC

2024

The Teaming Agreement between MRNA Scientific Sdn. Bhd. and Protech Builders Sdn. Bhd. for Biogas Plant Development, dated September 23, 2024

Development Agreements

BioNexus Gene Lab Coporation

2024

Development and Manufacturing Services Agreement, dated February 28, 2012, by and between the Registrant and Minaris Regenerative Medicine, LLC (formerly known as Hitachi Advanced...

Development Agreements

bluebird bio, Inc.

2024

Second Amendment to Development Funding and Royalties Agreement, dated November 28, 2023, by and between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc

Development Agreements

PIERIS PHARMACEUTICALS, INC.

2024

First Amendment to Development Funding and Royalties Agreement, dated May 22, 2020, by and between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc

Development Agreements

PIERIS PHARMACEUTICALS, INC.

2024

Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc

Development Agreements

PIERIS PHARMACEUTICALS, INC.

2024

English Translation of Second Addendum to Product Development Agreement, dated July 8, 2024

Development Agreements

AMARILLO BIOSCIENCES INC

2024

Joint Development and Option Agreement, dated May 3, 2024, between the Company and The Cleveland Clinic Foundation. (Certain information has been redacted in the marked portions...

Development Agreements

Anixa Biosciences Inc

2024

Third Amendment to GPEx Development and Manufacturing Agreement dated as of April 11, 2022 between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC

Development Agreements

DiaMedica Therapeutics Inc.

2024

Amendment No. 1 to Contract between the Company and the Biomedical Advanced Research and Development Authority, effective as of November 20, 2023

Development Agreements

Gritstone Oncology, Inc.

2024

Amended and Restated Development Services and Clinical Supply Agreement, dated November 9, 2023, by and between the Registrant and Catalent Maryland, Inc

Development Agreements

Passage BIO, Inc.

2024

Amendment No. 2 to Development Funding and Royalties Agreement, dated as of November 29, 2023, by and between the Company and Palvella Therapeutics, Inc

Development Agreements

Ligand Pharmaceuticals Incorporated

2024

Amendment No. 1 to Development Funding and Royalties Agreement, dated as of May 22, 2020, by and between the Company and Palvella Therapeutics, Inc

Development Agreements

Ligand Pharmaceuticals Incorporated

2024

Master Services Agreement for Drug Product Development and Manufacturing between Registrant and Lonza Ltd., dated March 22, 2022, as amended

Development Agreements

Vaxcyte, Inc.

2024

Amendment No. 1 to Amended and Restated Joint Development and Commercialization Agreement, dated December 23, 3023, between Vertex Pharmaceuticals Incorporated, Vertex...

Development Agreements

Vertex Pharmaceuticals Inc

2024

English Translation of Addendum to the Product Development Agreement, dated on January 9, 2024

Development Agreements

AMARILLO BIOSCIENCES INC

2024

English Translation of Product Development Agreement, dated on August 1, 2021

Development Agreements

AMARILLO BIOSCIENCES INC

2024

Amendment No. 1 to the Amended and Restated Joint Development and Commercialization Agreement, dated December 12, 2023, by and between, on the one hand, Vertex Pharmaceuticals...

Development Agreements

CRISPR Therapeutics AG

2023

Development and Manufacturing Services Agreement between Senti Biosciences, Inc. and GeneFab, LLC, dated August 7, 2023

Development Agreements

Dynamics Special Purpose Corp.

2023

Supplemental Agreement for nHCM, dated as of August 11, 2023, by and between MyoKardia, Inc., LianBio, LianBio Licensing, LLC, Lian Cardiovascular Limited, and Shanghai LianBio...

Development Agreements

LianBio

2023

Contract between the Company and the Biomedical Advanced Research and Development Authority, dated September 27, 2023

Development Agreements

Gritstone Oncology, Inc.

2023

Amendment No. 1 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...

Development Agreements

Vir Biotechnology, Inc.

2023

Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration for Strategic...

Development Agreements

Vir Biotechnology, Inc.

2023

Development and Supplemental Agreement between Elan Pharma International Limited and Acorda Therapeutics, Inc. dated January 14, 2011

Development Agreements

Alkermes plc.

2023

Commercial Agreement by and between the Company and the Lieber Institute for Brain Development dated October 13, 2023

Development Agreements

BullFrog AI Holdings, Inc.

2023

Development Agreement between Cardiff Oncology, Inc. and Pfizer, Inc. dated June 30, 2023

Development Agreements

Trovagene, Inc.

2023

Amendment of Solicitation/Modification of Contract, dated as of May 1, 2023 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S....

Development Agreements

T2 Biosystems, Inc.

2023

Commercialization Agreement, dated as of December 16, 2022, by and among LianBio Development (HK) Limited, LianBio Respiratory Limited, ReViral Ltd. and Pfizer Inc

Development Agreements

LianBio

Biotechnology

2023

Amendment Agreement No. 8 made and effective as of December 19, 2022 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd

Development Agreements

Adaptimmune Therapeutics PLC

Biotechnology

2022

Amendment to Development and Licensing Agreement, by and between the Company and Robert One, LLC, dated December 9, 2022

Development Agreements

Eagle Pharmaceuticals, Inc.

Biotechnology

2022

Therapeutic Development Award Agreement, by and between Arrevus, Inc. and Cystic Fibrosis Foundation, dated December 13, 2021

Development Agreements

IDERA PHARMACEUTICALS, INC.

Biotechnology

2022

Amendment of Solicitation/Modification of Contract, dated as of September 29, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the...

Development Agreements

T2 Biosystems, Inc.

Biotechnology

2022

Amendment of Solicitation/Modification of Contract between the Biomedical Advanced Research and Development Authority and ContraFect Corporation, dated August 24, 2022

Development Agreements

CONTRAFECT Corp

Biotechnology

2022

Amendment of Solicitation/Modification of Contract dated September 29, 2015 between the registrant and the U.S Department of Health and Human Services Biomedical Advanced Research...

Development Agreements

Avita Therapeutics, Inc.

Biotechnology

2022

Amendment of Solicitation/Modification of Contract dated September 29, 2015 between the registrant and the U.S Department of Health and Human Services Biomedical Advanced Research...

Development Agreements

Avita Therapeutics, Inc.

Biotechnology

2022

Portfolio Development Advisor Agreement dated September 6, 2022 between KEWAT, LLC and Moleculin Biotech, Inc

Development Agreements

Moleculin Biotech, Inc.

Biotechnology

2022

Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended

Development Agreements

Vaxcyte, Inc.

Biotechnology

2022

Cooperative Research and Development Agreement for Intramura-PhS Clinical Research

Development Agreements

Curative Biotechnology Inc

Biotechnology

2022

Category

Industry

Companies

Contracts

Development Agreements in the Biotechnology Industry